Chris Kodanidis

Chris Kodanidis, an editorial fellow at the New England Journal of Medicine, dives into the evolving role of beta blockers following heart attacks. He discusses the historical significance of these medications and critiques their effectiveness in light of the REDUCE-AMI trial findings. The conversation emphasizes the importance of individualized treatment approaches, challenging outdated norms in cardiology. Additionally, they explore Goodhart's Law and its implications on clinical decision-making, ultimately advocating for a more nuanced understanding of patient care.